Plasma Hepatocyte Growth Factor for Diagnosis and Prognosis in Light Chain and Transthyretin Cardiac Amyloidosis

OBJECTIVES: This study determined the diagnostic and prognostic usefulness of hepatocyte growth factor (HGF) in light chain and transthyretin cardiac amyloidosis. BACKGROUND: Delays in diagnosis of cardiac amyloidosis are common, usually resulting from nonspecific findings on clinical examination an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JACC CardioOncol
Autors principals: Zhang, Kathleen W., Miao, Jennifer, Mitchell, Joshua D., Alvarez-Cardona, Jose, Tomasek, Kelsey, Su, Yan Ru, Gordon, Mary, Cornell, R. Frank, Lenihan, Daniel J.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7717591/
https://ncbi.nlm.nih.gov/pubmed/33283202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaccao.2020.01.006
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars